Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Hydroxychloroquine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hydroxychloroquine (administration & dosage) < Hydroxychloroquine (adverse effects) < Hydroxychloroquine (analogs & derivatives)  Facettes :

List of bibliographic references indexed by Hydroxychloroquine (adverse effects)

Number of relevant bibliographic references: 339.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000004 (2021) Stéphane Honoré [France] ; Philippe Gautret [France]Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
000005 (2021) Elisa Baranski Lamback [Brésil] ; Monica Amorim De Oliveira [Brésil] ; Andrea Ferreira Haddad [Brésil] ; André Filipe Marcondes Vieira [Brésil] ; Armando Leão Ferreira Neto [Brésil] ; Taciana Da Silva Maia [Brésil] ; Juliana De Rezende Chrisman [Brésil] ; Pedro Pimenta De Mello Spineti [Brésil] ; Marco Antonio De Mattos [Brésil] ; Eduardo Costa [Brésil]Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19.
000017 (2021) Atiya R. Faruqui [Inde] ; Denis Xavier [Inde] ; Sandhya K. Kamat [Inde] ; Sujith J. Chandy [Inde] ; Bikash Medhi [Inde] ; Raakhi K. Tripathi [Inde] ; Yashashri C. Shetty [Inde] ; John Michael Raj [Inde] ; Sandeep Kaushal [Inde] ; S. Balakrishnan [Inde] ; Shubham Atal [Inde] ; Santanu K. Tripathi [Inde] ; Dinesh K. Badyal [Inde] ; Harihar Dikshit [Inde] ; Sukalyan Saha Roy [Inde] ; Niyati Trivedi [Inde] ; Suparna Chatterjee [Inde] ; Chetna Desai [Inde] ; C D Tripathi [Inde] ; Nirmala N. Rege [Inde] ; Pooja Gupta [Inde] ; R. Raveendran [Inde] ; Rajni Kaul [Inde] ; Nilima A. Kshirsagar [Inde]Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis.
000020 (2021) Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie][The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000021 (2021) Pierre Ekobena [Suisse] ; Anton Ivanyuk [Suisse] ; Françoise Livio [Suisse][Pharmacovigilance update].
000030 (2021) Rujittika Mungmunpuntipantip [Thaïlande] ; Viroj Wiwanitkit [Inde]Zebra-like bodies in COVID-19, hydroxychloroquine, and acute renal injury.
000031 (2021) Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie]Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
000032 (2021) Yesim Oymak ; Tuba H. Karapinar ; Lker Devrim [Turquie]Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
000042 (2021) Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne]Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
000045 (2021) Mudit Agarwal [Inde] ; Piyush Ranjan [Inde] ; Ankit Mittal [Inde] ; Upendra Baitha [Inde]Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.
000046 (2021) Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil]Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
000069 (2021) Waqas Aslam [Oman] ; Carla R. Lamb [États-Unis] ; Nadia Ali [États-Unis]Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
000070 (2021) Bagrat Lalabekyan [Royaume-Uni] ; Gudrun Kunst [Royaume-Uni] ; Vanessa A. Skelton [Royaume-Uni]Torsades de Pointes in Coronavirus Disease 2019 Infection.
000080 (2021) Rong Qiu ; Jingwei Li ; Yuxuan Xiao ; Ziyi Gao ; Yihang Weng ; Qiran Zhang ; Chengdi Wang ; Hanlin Gong [République populaire de Chine] ; Weimin LiThe therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.
000089 (2021) Kimberley Lewis [Canada] ; Dipayan Chaudhuri [Canada] ; Fayez Alshamsi [Émirats arabes unis] ; Laiya Carayannopoulos [Canada] ; Karin Dearness [Canada] ; Zain Chagla [Canada] ; Waleed Alhazzani [Canada]The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials.
000090 (2021) Anirban Hom Choudhuri [Inde] ; Sakshi Duggal [Inde] ; Bhuvna Ahuja [Inde] ; Partha Sarathi Biswas [Inde]The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 -a systematic review and meta-analysis.
000091 (2021) Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran]The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
000099 (2021) Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada]The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000121 (2021) Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
000135 (2021) Baptiste Maille [France] ; Marie Wilkin [France] ; Matthieu Million [France] ; Noémie Rességuier [France] ; Frédéric Franceschi [France] ; Linda Koutbi-Franceschi [France] ; Jérôme Hourdain [France] ; Elisa Martinez [France] ; Maxime Zabern [France] ; Christophe Gardella [France] ; Hervé Tissot-Dupont [France] ; Jagmeet P. Singh [États-Unis] ; Jean-Claude Deharo [France] ; Laurent Fiorina [France]Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Hydroxychloroquine (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Hydroxychloroquine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Hydroxychloroquine (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021